NCT03633513终止不适用
Inflammatory Parkinson's Disease (PD) Clinical Biomarker Profiling in T Cells
Longevity Biotech2 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2018年7月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 99
- 试验地点
- 2
- 主要终点
- Unified Parkinson Disease Rating Scale
研究概览
简要总结
This study compares a comprehensive panel of immunological biomarkers between Parkinson's disease patients and healthy, environmentally matched participants. This unique study design provides the ability to control for differences in environment between study subjects. The goal of this study is to 1) identify a specific set of immunological markers that correlate with a clinical diagnosis of Parkinson's disease and 2) stratify patients by disease severity using these same biomarkers.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 89 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Unified Parkinson Disease Rating Scale
时间窗: 1 hour
Clinical scoring system to evaluate severity of Parkinson's disease in patients
次要结局
- Interleukin-17(48 hours)
- Interferon gamma(48 hours)
- FoxP3(48 hours)
- GM-CSF(48 hours)
- VPAC2(48 hours)
- Tumor necrosis factor alpha(48 hours)
- LRRK2(48 hours)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Biomarkers for differentiation of Parkinson*s disease subtypes.Parkinson's10028037NL-OMON39292eids Universitair Medisch Centrum210
Unknown
不适用
New Biomarkers in Parkinson's DiseaseParkinson DiseaseNCT05150158Neuromed IRCCS60
招募中
不适用
Serum Biomarkers in Parkinson's Disease at Different StagesParkinson DiseaseNCT05769699Fondazione Policlinico Universitario Agostino Gemelli IRCCS200
招募中
不适用
Autoimmune Features of Neurodegenerative DisordersMild Cognitive ImpairmentAlzheimer DiseaseParkinson DiseaseNCT04239079Columbia University120
终止
不适用
Functional Characterization of Parkin + PatientsParkinson's DiseaseNCT00142311Institut National de la Santé Et de la Recherche Médicale, France97